Author

David Obermeier

German Cancer Research Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2

Frequent Co-Authors

Ana BanitoiD· 2 shared Florencia Cidre‐AranaziD· 2 shared Florian H. GeyeriD· 2 shared Malenka ZimmermanniD· 2 shared Roland ImleiD· 2 shared Thomas G. P. GrünewaldiD· 2 shared A. Katharina CeranskiiD· 1 shared Alina DahlhausiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Ana BanitoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Targeting CXADR-mediated AKT signaling suppresses tumorigenesis and enhances chemotherapy efficacy in Ewing sarcoma

Alina Ritter, Malenka Zimmermann, Florian H. Geyer, Pablo Táboas, David Obermeier, Martha J. Carreño Gonzalez, Kimberley M. Hanssen, Tobias Faehling, Jana Siebenlist, Annika Jeschke, Laura Romero‐Pérez, Roland Imle, Ana Banito, Enrique de Álava, Wolfgang Hartmann, , Florencia Cidre‐Aranaz

This study identifies CXADR as a driver of Ewing sarcoma metastasis and shows that targeting AKT signaling with Capivasertib enhances chemotherapy efficacy in CXADR-high tumors.

bioRxiv · Aug 7, 2025 · PreprintCancer Biology

Glutaredoxin 3 (GLRX3) confers a fusion oncogene-dependent vulnerability to Ewing sarcoma

Endrit Vinca, Anna C. Ehlers, Alina S. Ritter, David Obermeier, Cornelius Maximilian Funk, Florian H. Geyer, Melissa Schmucker, Jing Li, Malenka Zimmermann, A. Katharina Ceranski, Fabia Fuchslocher, Christina Mertens, Ruiyue Qiu, Martina Ulrike Muckenthaler, Alina Dahlhaus, , Shunya Ohmura

This study identifies GLRX3 as a vulnerability in Ewing sarcoma driven by EWSR1::FLI1 fusion oncoproteins, showing its role in oxidative stress and iron homeostasis and potential therapeutic targeting.

bioRxiv · Apr 24, 2024 · PreprintCancer Biology